Delhi Chemical & Pharmaceutical Works Profile
Key Indicators
- Authorised Capital ₹ 0.25 M
- Paid Up Capital ₹ 0.10 M
- Company Age 54 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 95.53%
- Ebitda 95.87%
- Net Worth -0.20%
- Total Assets -0.01%
About Delhi Chemical & Pharmaceutical Works
Delhi Chemical & Pharmaceutical Works Private Limited (DCPWPL) was founded in India on 18 January 1971 and has a glorious history of 54 years and one month.Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.25 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samir Sharma and Ameet Sharrma serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1971PTC005507
- Company No.
005507
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1971
- Date of AGM
26 Oct 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Delhi Chemical & Pharmaceutical Works?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ameet Sharrma  | Managing Director | 14-Jun-2006 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samir Sharma | Director | 14-Jun-2006 | Current |
Financial Performance of Delhi Chemical & Pharmaceutical Works.
Delhi Chemical & Pharmaceutical Works Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.53% increase in profit. The company's net worth dipped by a decrease of 0.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Delhi Chemical & Pharmaceutical Works?
Unlock access to Delhi Chemical & Pharmaceutical Works's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Trustline Real Estate Private LimitedSamir Sharma is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Delhi Chemical & Pharmaceutical Works?
Unlock and access historical data on people associated with Delhi Chemical & Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Delhi Chemical & Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delhi Chemical & Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.